Clinical Trials Update: Apr. 19, 2010

By on April 19, 2010

Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Depression

This study aims to determine whether certain proteins in the blood related to inflammation and neuroendocrine function can serve as markers of depression. The study involves a single visit for a clinical interview and blood draw and a follow-up phone call 8 to 12 weeks later. The research site is in Brighton, Mass.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/depression.aspx.

—–

Alzheimer’s Disease or Medication for Memory Loss

This study is trying to find people who are taking medications for memory loss or have mild-to-moderate Alzheimers disease. Qualified participants will receive study-related health assessments and investigational drugs at no cost and study-related care from the study doctor at the healthcare facility. The research site is in Oklahoma City, Okla.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/alzheimer’s_disease.aspx.

—–

Healthy, White Volunteers

This study is for an investigational study drug. To qualify, you must be healthy, white and between 20 and 45 years old. Qualified participants may receive study-related services at no cost and compensation up to $1,860. The research site is in Glendale, Calif.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/healthy_volunteers.aspx.

—–

Copyright 2010ClinicalConnection.com. All rights reserved.

Source: HealthDay

Leave a Reply

Your email address will not be published. Required fields are marked *